Merck Withdraws Fosamax UK Ad Claiming Superiority To Generic
This article was originally published in The Pink Sheet Daily
Executive Summary
UK Merck subsidiary issues corrective statement acknowledging no superiority over Teva’s generic alendronic acid, as required by the British Medicines & Healthcare products Regulatory Agency.